Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

A Real-World Comparison of CAR T-Cell Therapy Versus a Historical Standard-of-Care Approach for Relapsed-Refractory Large B-Cell Lymphoma in Ontario, Canada

Tiana Kordbacheh, Anca Prica, Kelvin KW Chan, Mahmood Aminilari, Zharmaine Ante, Ning Liu, Inna Y Gong, Sita Bhella, Michael Crump, Abi Vijenthira, John Kuruvilla, Robert Kridel, Christine I Chen, Vishal Kukreti, Chloe Yang, Nauman Malik, David Hodgson, Danielle Rodin

Blood (2024) 144 (Supplement 1): 5134.

https://doi.org/10.1182/blood-2024-206375

Published: 2024

Journal Articles

Real-World Comparison of Healthcare Costs and Resource Utilization Among Patients with Relapsed-Refractory Large B-Cell Lymphoma Treated with CAR T-Cell Therapy Versus Historical Standard-of-Care: A Cost-Consequence Analysis in Ontario, Canada

Tiana Kordbacheh, Anca Prica, Kelvin KW Chan, Mahmood Aminilari, Zharmaine Ante, Ning Liu, Inna Y Gong, Sita D. Bhella, Michael Crump, Abi Vijenthira, John Kuruvilla, Robert Kridel, Christine I Chen, Vishal Kukreti, Chloe Yang, Nauman Malik, David Hodgson, Danielle Rodin

Blood (2024) 144 (Supplement 1): 2272.

https://doi.org/10.1182/blood-2024-201539

Published: 2024

Journal Articles

Assessing the Impact of Marginalization on Survival for Patients Undergoing Allogeneic Stem Cell Transplant in Ontario, Canada

Adam Suleman, Sho Podolsky, Ning Liu, Kelvin KW Chan, Sumedha Arya, Lisa Hicks, Matthew C. Cheung, Anca Prica

Blood (2023) 142 (Supplement 1): 5175.

https://doi.org/10.1182/blood-2023-185351

Published: 2023

Journal Articles

Outcomes of Transplant-Eligible and Transplant-Ineligible Patients with Mantle Cell Lymphoma in Ontario, Canada

Adam Suleman, Zharmaine Ante, Ning Liu, Michael Crump, Kelvin KW Chan, Matthew C. Cheung, Anca Prica

Blood (2023) 142 (Supplement 1): 1665.

https://doi.org/10.1182/blood-2023-177788

Published: 2023

Journal Articles

Assessing the Impact of Marginalization on Survival for Patients Undergoing Autologous Stem Cell Transplant in Ontario, Canada

Adam Suleman, Sho Podolsky, Ning Liu, Kelvin KW Chan, Sumedha Arya, Lisa Hicks, Matthew C. Cheung, Anca Prica

Blood (2023) 142 (Supplement 1): 2389.

https://doi.org/10.1182/blood-2023-173609

Published: 2023

Journal Articles

Comparison of the Efficacy in Clinical Trials Versus Effectiveness in the Real-World of Treatments for Multiple Myeloma: A Population-Based Cohort Study

Alissa Visram, Kelvin KW Chan, Hsien Seow, Gregory Pond, Ana Gayowsky, Arleigh McCurdy, Irwindeep Sandhu, Christopher P. Venner, Guido Lancman, Amaris Balitsky, Robert Bruins, Shaji Kunnathu Kumar, Rafael Fonseca, Hira Mian

Blood (2023) 142 (Supplement 1): 541.

https://doi.org/10.1182/blood-2023-189506

Published: 2023

Journal Articles

The Impact of Drug Interactions on Outcomes in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia in Routine Clinical Care: A Population-Based Cohort Study

Tuan Hoang, Matthew C. Cheung, Kelvin KW Chan, Cindy Lau, Ning Liu, Husam Abdel-Qadir, David Juurlink, Anca Prica, Alia Thawer, Abi Vijenthira, Lee Mozessohn

Blood (2022) 140 (Supplement 1): 2159–2160.

https://doi.org/10.1182/blood-2022-158768

Published: 2022

Journal Articles

Granulocyte-Colony Stimulating Factor (G-CSF) in Secondary Prophylaxis for Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Cost-Effectiveness Analysis

Matthew C Cheung, Anca Prica, MD, Joanna Graczyk, MD, Rena Buckstein, MD, Kelvin KW Chan, MD

Blood (2014) 124 (21): 737.

https://doi.org/10.1182/blood.V124.21.737.737

Published: 2014

Journal Articles

Frontline Rituximab Monotherapy Induction Versus a Watch and Wait Approach For Asymptomatic Advanced Stage Follicular Lymphoma: A Cost-Effectiveness Analysis

Anca Prica, MD, Kelvin KW Chan, MD, Matthew C Cheung, MD

Blood (2013) 122 (21): 2941.

https://doi.org/10.1182/blood.V122.21.2941.2941

Published: 2013

Journal Articles

Adjusting For Drug Wastage In Economic Evaluations Of New Therapies For Hematologic Malignancies: A Systematic Review Of The Literature and Implications

Matthew C. Cheung, MD, Maureen E. Trudeau, Anca Prica, MD, Rena Buckstein, MD, Kelvin KW Chan, MD

Blood (2013) 122 (21): 2928.

https://doi.org/10.1182/blood.V122.21.2928.2928

Published: 2013

Journal Articles

Combined Modality Therapy Versus Chemotherapy Alone As an Induction Regimen for Primary CNS Lymphoma: A Cost-Effectiveness Analysis

Anca Prica, MD, Kelvin KW Chan, MD, MSc, FRCPC, Matthew Cheung, MD, MS, FRCP

Blood (2012) 120 (21): 969.

https://doi.org/10.1182/blood.V120.21.969.969

Published: 2012

Journal Articles

Publication Patterns of Cancer Cost-Effectiveness Studies Presented at the American Society of Hematology: Timeliness of Publication, Quality and Possible Bias.

Lee Mozessohn, MD, Kelvin KW Chan, MD, MSc, FRCPC, Matthew C Cheung, MD, SM, FRCPC

Blood (2010) 116 (21): 3816.

https://doi.org/10.1182/blood.V116.21.3816.3816

Published: 2010

Journal Articles

With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially? [letter]

M Korbling, D Przepiorka, J Gajewski, RE Champlin, KW Chan

Blood (1995) 86 (3): 1235.

https://doi.org/10.1182/blood.V86.3.1235.1235

Published: 1995

Journal Articles

Obstructive lung disease in children after allogeneic bone marrow transplantation

KR Schultz, GJ Green, D Wensley, MA Sargent, JF Magee, JJ Spinelli, S Pritchard, JH Davis, PC Rogers, KW Chan

Blood (1994) 84 (9): 3212–3220.

https://doi.org/10.1182/blood.V84.9.3212.3212

Published: 1994

Journal Articles

In vitro cell growth in neonates with Down's syndrome and transient myeloproliferative disorder

JF Denegri, PC Rogers, KW Chan, J Sadoway, JW Thomas

Blood (1981) 58 (4): 675–677.

https://doi.org/10.1182/blood.V58.4.675.675

Published: 1981

NARROW

A Real-World Comparison of CAR T-Cell Therapy Versus a Historical Standard-of-Care Approach for Relapsed-Refractory Large B-Cell Lymphoma in Ontario, Canada

Real-World Comparison of Healthcare Costs and Resource Utilization Among Patients with Relapsed-Refractory Large B-Cell Lymphoma Treated with CAR T-Cell Therapy Versus Historical Standard-of-Care: A Cost-Consequence Analysis in Ontario, Canada

Assessing the Impact of Marginalization on Survival for Patients Undergoing Allogeneic Stem Cell Transplant in Ontario, Canada

Outcomes of Transplant-Eligible and Transplant-Ineligible Patients with Mantle Cell Lymphoma in Ontario, Canada

Assessing the Impact of Marginalization on Survival for Patients Undergoing Autologous Stem Cell Transplant in Ontario, Canada

Comparison of the Efficacy in Clinical Trials Versus Effectiveness in the Real-World of Treatments for Multiple Myeloma: A Population-Based Cohort Study

The Impact of Drug Interactions on Outcomes in Ibrutinib-Treated Patients with Chronic Lymphocytic Leukemia in Routine Clinical Care: A Population-Based Cohort Study

Granulocyte-Colony Stimulating Factor (G-CSF) in Secondary Prophylaxis for Advanced-Stage Hodgkin Lymphoma Treated with ABVD Chemotherapy: A Cost-Effectiveness Analysis

Frontline Rituximab Monotherapy Induction Versus a Watch and Wait Approach For Asymptomatic Advanced Stage Follicular Lymphoma: A Cost-Effectiveness Analysis

Adjusting For Drug Wastage In Economic Evaluations Of New Therapies For Hematologic Malignancies: A Systematic Review Of The Literature and Implications

Combined Modality Therapy Versus Chemotherapy Alone As an Induction Regimen for Primary CNS Lymphoma: A Cost-Effectiveness Analysis

Publication Patterns of Cancer Cost-Effectiveness Studies Presented at the American Society of Hematology: Timeliness of Publication, Quality and Possible Bias.

With first successful allogeneic transplantations of apheresis-derived hematopoietic progenitor cells reported, can the recruitment of volunteer matched, unrelated stem cell donors be expanded substantially? [letter]

Obstructive lung disease in children after allogeneic bone marrow transplantation

In vitro cell growth in neonates with Down's syndrome and transient myeloproliferative disorder

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only